Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Sana Reveals Cash Haul Of $700m In Under Two Years

Jun 23 2020

• By Mandy Jackson

Finance Watch

Related Content

mRNA Vaccines – Trials Line Up Against Coronavirus

Apr 01 2020

Keeping Track: Targeted Oncologics Take Center Stage, Led By Retevmo And Tabrecta Approvals

May 12 2020

Celgene Seeks CAR-T Leadership, Hematology Diversification With Juno Buy

Jan 23 2018

VC Funding: Increasing Prior Rounds; New Strategy In Lieu Of An IPO?

Mar 30 2016

Finance Watch: Three New Funds, Including Former Amgen R&D Head Harper's Next Venture

Sep 07 2018

Finance Watch: Pfizer Ventures' Dalton Makes Sense Of Neuroscience Focus Within New $600m VC Fund Commitment

Jun 13 2018

C4 Therapeutics Start-up Starts With Roche Tie-Up, $73m Series A

Jan 07 2016

J.P. Morgan 2019: Biopharma Sentiment Soars As Deal And Financing Optimism Abounds

Jan 14 2019

Bristol’s CAR-T Strategy Comes Into Focus With Two Near-Term Filings

Dec 10 2019

Finance Watch: Flagship Raises $824m To Speed Growth Of Its Portfolio Companies

Mar 22 2019

Related Companies

Sana Biotechnology, Inc.

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Stanford University

C4 Therapeutics, Inc.

Roche Holding AG

Calico Life Sciences, LLC

Biogen, Inc.

Takeda Pharmaceutical Co. Ltd.

4D Molecular Therapeutics

Cystic Fibrosis Foundation

Surrozen Inc.

etherna Immunotherapies

CSL Limited

Additional Topics

Financing Innovation StartUps and SMEs Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window